Viewing Study NCT04906733


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-01-01 @ 5:49 AM
Study NCT ID: NCT04906733
Status: UNKNOWN
Last Update Posted: 2021-08-13
First Post: 2021-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
Sponsor: D1 Medical Technology (Shanghai) Co., Ltd, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module